Publicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (13)

2024

  1. Erythropoietin restrains the inhibitory potential of interneurons in the mouse hippocampus

    Molecular Psychiatry

2023

  1. Multifactorial Causation of Alzheimer's Disease Due to COVID-19

    Journal of Alzheimer's Disease, Vol. 96, Núm. 4, pp. 1399-1409

2022

  1. Hyperammonemia Alters the Function of AMPA and NMDA Receptors in Hippocampus: Extracellular cGMP Reverses Some of These Alterations

    Neurochemical Research, Vol. 47, Núm. 7, pp. 2016-2031

2021

  1. Electroencephalography as a non-invasive biomarker of alzheimer’s disease: A forgotten candidate to substitute CSF molecules?

    International Journal of Molecular Sciences, Vol. 22, Núm. 19

  2. Induced dipoles and possible modulation of wireless effects in implanted electrodes. Effects of implanting insulated electrodes on an animal test to screen antidepressant activity

    Journal of Clinical Medicine, Vol. 10, Núm. 17

  3. Is Oxidative Stress the Link Between Cerebral Small Vessel Disease, Sleep Disruption, and Oligodendrocyte Dysfunction in the Onset of Alzheimer’s Disease?

    Frontiers in Physiology, Vol. 12

2020

  1. Hyperammonemia alters the mismatch negativity in the auditory evoked potential by altering functional connectivity and neurotransmission

    Journal of Neurochemistry, Vol. 154, Núm. 1, pp. 56-70

  2. Is sleep disruption a cause or consequence of alzheimer’s disease? Reviewing its possible role as a biomarker

    International Journal of Molecular Sciences, Vol. 21, Núm. 3

  3. Perineuronal Nets Regulate the Inhibitory Perisomatic Input onto Parvalbumin Interneurons and γ Activity in the Prefrontal Cortex

    The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 40, Núm. 26, pp. 5008-5018

2019

  1. Lack of MeCP2 leads to region-specific increase of doublecortin in the olfactory system

    Brain Structure and Function, Vol. 224, Núm. 4, pp. 1647-1658

  2. Obesity as a risk factor for Alzheimer's disease: Implication of leptin and glutamate

    Frontiers in Neuroscience, Vol. 13, Núm. MAY

  3. The effectiveness of vitamin E treatment in alzheimer’s disease

    International Journal of Molecular Sciences, Vol. 20, Núm. 4

  4. When does Alzheimer′s disease really start? The role of biomarkers

    International Journal of Molecular Sciences, Vol. 20, Núm. 22